Cialis Overdose and Accidental Excess Dose: What to Do and What to Expect

Tadalafil is the generic name for the drug sold under the brand name Cialis for erectile dysfunction and benign prostatic hyperplasia, and under the brand name Adcirca for pulmonary arterial hypertension. It belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, the same drug class as sildenafil (Viagra) and vardenafil (Levitra), though its longer half-life sets it apart clinically, especially in an overdose.

Tadalafil overdose is not established as directly lethal in the published literature: healthy volunteers in early-phase safety studies tolerated single doses many-fold above the approved 20 mg maximum without cardiovascular collapse. The clinically significant risks are symptomatic hypotension, which becomes dangerous mainly when tadalafil is combined with nitrates or alpha-blockers, and priapism, which is a genuine urologic emergency once an erection has lasted more than four hours. No specific antidote exists, and there is no established numeric "toxic dose" threshold in humans; management is guided entirely by symptoms and by what else the person has taken.

How Tadalafil Works and Why the Dose Matters

Tadalafil blocks the enzyme PDE5, which normally breaks down cyclic guanosine monophosphate (cGMP) in vascular smooth muscle. Blocking PDE5 lets blood vessels relax and fill with blood. In the penis, this produces an erection when sexual stimulation triggers nitric oxide release. The same vasodilation happens throughout the body, which is why tadalafil is also FDA-approved for pulmonary arterial hypertension and for benign prostatic hyperplasia, and why systemic side effects (headache, flushing, low blood pressure) scale with dose.

Why the Long Half-Life Changes the Overdose Picture

Tadalafil's half-life of roughly 17.5 hours is markedly longer than sildenafil's. This means supratherapeutic drug levels persist much longer after an accidental extra dose. Someone who doubles a 20 mg on-demand dose to 40 mg can carry meaningful PDE5 inhibition for well over 24 hours, and symptoms can appear delayed and last longer than a person might expect from a single tablet.

Recognizing Overdose Symptoms

The symptom pattern in overdose is the same pharmacology seen at therapeutic doses, just amplified.

Cardiovascular Symptoms

Systemic vasodilation is the dominant risk. Blood pressure can drop enough to cause dizziness, lightheadedness, or fainting. Reflex tachycardia is common as the heart compensates for lower peripheral resistance. Patients on antihypertensives or nitrates face substantially higher risk of hemodynamic collapse than healthy patients not on those medications.

Headache and Musculoskeletal Symptoms

Headache is consistently reported as the most common adverse effect of tadalafil at the approved dose in clinical trials, occurring more often than with placebo. Exact rate figures vary between studies and should be confirmed against the primary trial report before being quoted precisely in clinical materials; this article does not attach a specific percentage because the underlying citation could not be verified during this review. Back pain and muscle aches, thought to reflect PDE5 inhibition in vascular smooth muscle, tend to become more noticeable at higher exposures.

Priapism

A prolonged erection (priapism) is a low-frequency but high-severity risk shared across the PDE5 inhibitor class. An erection lasting more than four hours is a urologic emergency because a prolonged low-flow (ischemic) state can cause corporal smooth muscle damage and permanent erectile dysfunction if left untreated. Risk rises with overdose, concurrent injection therapy for ED (alprostadil), sickle cell disease, and certain blood cancers such as leukemia and multiple myeloma.

Vision and Hearing Changes

At therapeutic doses tadalafil has less cross-reactivity with PDE6, the retinal enzyme, than sildenafil does, which is why color-vision changes are reported less often with tadalafil. At much higher exposures, PDE6 effects may become more relevant. Sudden sensorineural hearing loss has been reported in postmarketing surveillance across the PDE5 inhibitor class; whether the drugs actually cause it, rather than coincide with it, remains debated in the literature and is not established.

What Is Established, What Is Plausible, What Is Not Established

Established: Tadalafil's mechanism, its approved dosing ceilings, its long half-life relative to sildenafil, the danger of combining it with nitrates, and priapism as a class risk requiring treatment within hours are all supported by the FDA label and are not seriously disputed.

Plausible but unproven: A causal link between PDE5 inhibitors and sudden hearing loss is reported but not established as causal. The tolerability seen in healthy volunteers given large single doses in early trials is reassuring but has not been formally tested in people with significant cardiovascular disease, hepatic impairment, or advanced age at similarly high doses.

Not established: There is no confirmed human lethal dose for tadalafil taken alone in the literature reviewed for this article, and there is no validated numeric threshold at which overdose symptoms reliably begin. Individual risk depends heavily on co-ingestants, comorbidities, and concurrent medications, not on a single milligram cutoff.

Immediate Steps After a Suspected Overdose

Most tadalafil exposures in healthy adults resolve with supportive care, and panic is not useful. A calm, stepwise check matters more than speed alone.

Step 1: Work Out the Total Dose Taken

Add up the total milligrams ingested. Two 20 mg tablets (40 mg) is a very different situation than an entire bottle. Check the label for tablet strength and count remaining pills. If the person also takes a daily 5 mg dose, factor in that steady-state levels build up over about five days of daily dosing, per the FDA label.

Step 2: Check for High-Risk Co-Ingestants

The most dangerous combination is tadalafil with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or recreational nitrates ("poppers," amyl nitrite). This combination can cause severe, potentially life-threatening hypotension. The FDA label contraindicates concurrent nitrate use and specifies a washout period after tadalafil before nitrates can be given. Alpha-blockers (tamsulosin, doxazosin) and riociguat also add to hypotension risk.

Step 3: Call Poison Control or Go to the ED

Call the American Association of Poison Control Centers at 1-800-222-1222 for real-time guidance. Go directly to an emergency department for hypotension symptoms, chest pain, fainting, or an erection that has already lasted, or is approaching, four hours.

A Decision Framework for Accidental Excess-Dose Situations

The right response depends on three things: how much was taken, what else the person takes or has taken, and whether warning symptoms are present. This framework is meant to organize thinking, not to replace a call to Poison Control or a clinician.

Emergency Department Management

There is no specific antidote for tadalafil. Treatment is supportive and follows the presenting symptoms.

Hemodynamic Support

For symptomatic hypotension, initial management typically involves positioning and IV normal saline boluses. If fluids do not restore adequate blood pressure, vasopressors such as norepinephrine or phenylephrine are the next step, guided by continuous cardiac monitoring. Because of tadalafil's long half-life, hemodynamic instability can persist for many hours after a large ingestion, longer than would be expected with a shorter-acting PDE5 inhibitor.

Gastrointestinal Decontamination

Activated charcoal may be considered if the person presents within roughly one hour of ingestion and can protect their airway, per general toxicology practice for oral overdoses (see Goldfrank's Toxicologic Emergencies for general principles of supportive care in vasodilatory drug overdose). Because tadalafil reaches peak plasma concentration around two hours after ingestion, the window in which charcoal is likely to help is narrow. Gastric lavage is not routinely used for PDE5 inhibitor overdose given the low reported lethality.

Priapism Management

An erection lasting more than four hours needs urgent urologic evaluation. Standard management involves corporal aspiration, and if that fails, intracavernosal injection of a vasoconstrictor such as phenylephrine, with surgical shunting reserved for refractory cases. Blood gas analysis of aspirated corporal blood helps distinguish an ischemic (low-flow) from a non-ischemic (high-flow) priapism, since the two have different management pathways. This is specialized urologic care, not something to attempt outside a medical setting.

How Long to Monitor

Given the roughly 17.5-hour half-life, patients with significant symptoms are generally monitored for several hours after symptoms resolve rather than discharged as soon as they feel better, because a rebound in symptoms is plausible. Asymptomatic patients after a modest excess dose (for example, 40 mg in an otherwise healthy adult) are often observed for a shorter period and discharged if vital signs stay stable, at clinician discretion.

Pharmacokinetics That Explain the Overdose Time Course

Absorption and Elimination

Tadalafil is metabolized mainly through the liver enzyme CYP3A4. Its main circulating metabolite is far less potent against PDE5 than the parent drug and is generally considered inactive at the levels produced by normal dosing. Elimination is split between the kidneys and the gut, and food does not meaningfully change how much or how fast the drug is absorbed, so a full stomach at the time of an overdose does not reliably delay onset.

Interactions That Effectively Multiply the Dose

Strong CYP3A4 inhibitors, such as ketoconazole, ritonavir, and clarithromycin, substantially raise tadalafil blood levels. According to the FDA label, ketoconazole increased tadalafil's total drug exposure several-fold in a pharmacokinetic study; a patient taking a standard tadalafil dose while also on a strong CYP3A4 inhibitor such as ritonavir-based antiretroviral therapy can end up with an effective exposure well above what the prescribed dose would normally produce. The FDA label recommends reduced tadalafil dosing and longer intervals between doses for patients on potent CYP3A4 inhibitors. In hepatic impairment (Child-Pugh Class A or B), clearance is also reduced, and the label caps the recommended dose accordingly. Both situations mean an "ordinary" dose can behave like a mild overdose in these patients.

Older Adults

Healthy volunteers aged 65 and older showed higher tadalafil exposure than younger subjects in the pharmacokinetic studies underlying the FDA label. Combined with age-related declines in liver blood flow and kidney function, older adults clear the drug more slowly, and pre-existing orthostatic hypotension in this group compounds tadalafil's vasodilatory effects.

Nitrates and Cardiovascular Disease Deserve Separate Emphasis

Cardiology and urology guidance groups treat the combination of tadalafil and nitrates as a hazard to be avoided outright, not managed carefully, because both drug classes amplify the nitric oxide-cGMP pathway at different points simultaneously and can produce dangerous, difficult-to-reverse hypotension. Patients with unstable angina, a recent heart attack, decompensated heart failure, or severely uncontrolled hypertension are considered at higher baseline risk from tadalafil exposure, and an overdose in these patients warrants a lower threshold for hospital-level monitoring. Specific numeric data from trials regarding tadalafil interactions cited in earlier drafts could not be verified against the primary literature during this review and have been removed rather than presented as precise figures; the qualitative interaction risk itself is well established and not in dispute.

Accidental Double-Dosing: The Most Common Real-World Scenario

Most tadalafil "overdoses" reported are accidental double-doses rather than intentional large ingestions: a person on daily 5 mg forgets a morning dose and takes it late, then takes the next day's dose only a few hours later; or someone using 20 mg on-demand takes a second tablet because the first "didn't seem to work."

For a healthy adult with no nitrate use and no significant cardiovascular disease, the available trial data on tadalafil at doses above 20 mg suggest that adverse effects at that level are mostly an intensified version of the usual side effects, chiefly headache and flushing, without reports of serious cardiovascular events in healthy volunteers. That reassurance does not extend to patients on interacting medications, older adults, or people with cardiovascular or hepatic disease, where the same numeric dose carries more risk.

The situation changes meaningfully for someone on an alpha-blocker for BPH, since tamsulosin combined with tadalafil at approved doses already produces a measurable blood pressure drop; doubling the tadalafil dose on top of that combination is not the same low-risk scenario as a double dose in a person on no other medication.

Preventing Accidental Overdose

Patients on daily low-dose tadalafil (2.5 mg or 5 mg, typically for BPH or ED) benefit from a pill organizer to track whether a dose was already taken that day. On-demand users can note the time of each dose. A labeled phone alarm is a simple, low-effort safeguard against re-dosing too soon.

It is also worth confirming with a prescriber whether a person is meant to be on daily dosing, on-demand dosing, or neither at the same time, since the two regimens are not meant to be combined. A patient prescribed daily 5 mg who also takes an on-demand 20 mg dose before sexual activity has taken 25 mg that day, above the labeled ceiling for either regimen alone, and this kind of overlap is a recognized way that patients end up unintentionally over-dosed when instructions come from more than one source or visit.

Long-Term Outlook After a Single Overdose Event

A single tadalafil overdose in an otherwise healthy adult, even well above 20 mg, is not associated with documented long-term cardiovascular or neurologic effects in the literature reviewed here. The clear exception is priapism: untreated ischemic priapism beyond roughly 24 to 36 hours can cause corporal tissue damage and permanent erectile dysfunction. That is why the four-hour rule for a persistent erection is treated as non-negotiable rather than a soft guideline. Seek care at the four-hour mark, not after trying to wait it out.